Ratings by RBC Capital (Leonid Timashev)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Nuvation Bio Inc | NUVB | Maintain | (N/A) |
|
Details | ||
| 3/3/2026 | Biohaven Pharma | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2026 | Exelixis | EXEL | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/26/2026 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2026 | Alkermes | ALKS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2026 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2026 | Compass Pathways | CMPS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2026 | Perspective Therapeutics Inc | CATX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2026 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2026 | Exelixis | EXEL | Maintain | (N/A) |
|
Details | ||
| 2/2/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2026 | Compass Pathways | CMPS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | CG Oncology | CGON | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | CorMedix | CRMD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Revolution | RVMD | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/21/2026 | Biohaven Pharma | BHVN | Upgrade | Outperform (Sector Perform) |
12.68 (9.92) |
-21.77% | Details | |
| 1/6/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 12/29/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2025 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2025 | Pyxis Oncology Inc. | PYXS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2025 | Design Therapeutics Inc | DSGN | Upgrade | Outperform (Sector Perform) |
7.34 (10.05) |
36.92% | Details | |
| 11/18/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2025 | CG Oncology | CGON | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2025 | Jasper Therapeutics | JSPR | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2025 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Xencor, Inc. | XNCR | Maintain | (N/A) |
|
Details | ||
| 11/6/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | (N/A) |
|
Details | ||
| 11/6/2025 | Design Therapeutics Inc | DSGN | Maintain | (N/A) |
|
Details | ||
| 11/5/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Alkermes | ALKS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Verastem | VSTM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2025 | Compass Pathways | CMPS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2025 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2025 | Revolution | RVMD | New Coverage | Outperform (N/A) |
58.87 (98.40) |
67.15% | Details | |
| 10/31/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2025 | Bicycle Therapeutics | BCYC | Downgrade | Sector Perform (Outperform) |
8.18 (5.19) |
-36.55% | Details | |
| 10/27/2025 | Xencor, Inc. | XNCR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Alkermes | ALKS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2025 | CorMedix | CRMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/21/2025 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2025 | CorMedix | CRMD | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Alkermes | ALKS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2025 | Alkermes | ALKS | Upgrade | Outperform (Sector Perform) |
27.13 (28.63) |
5.53% | Details | |
| 9/12/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2025 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/20/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2025 | Bicycle Therapeutics | BCYC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2025 | Alkermes | ALKS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/29/2025 | Exelixis | EXEL | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/16/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 7/9/2025 | Ideaya Biosciences | IDYA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Exelixis | EXEL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | CorMedix | CRMD | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2025 | BeOne Medicines | ONC | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2025 | Nuvation Bio Inc | NUVB | Maintain | Outperform (N/A) |
|
Details | ||
| 6/11/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2025 | Alkermes | ALKS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/5/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2025 | Design Therapeutics Inc | DSGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 6/3/2025 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/2/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/19/2025 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Sector Perform (Outperform) |
16.02 (12.68) |
-20.85% | Details | |
| 5/16/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2025 | Alkermes | ALKS | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/3/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2025 | Insmed | INSM | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2025 | Alkermes | ALKS | New Coverage | Sector Perform (N/A) |
33.41 (27.13) |
-18.8% | Details | |
| 3/12/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2025 | Design Therapeutics Inc | DSGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/4/2025 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2025 | Insmed | INSM | New Coverage | Outperform (N/A) |
81.06 (140.13) |
72.87% | Details | |
| 2/19/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 12/20/2024 | Pyxis Oncology Inc. | PYXS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2024 | Cytokinetics | CYTK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/4/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/21/2024 | Pyxis Oncology Inc. | PYXS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2024 | Cytokinetics | CYTK | New Coverage | Outperform (N/A) |
55.50 (60.41) |
8.85% | Details | |
| 11/1/2024 | Compass Pathways | CMPS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/20/2024 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 7/26/2024 | Pyxis Oncology Inc. | PYXS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/23/2024 | Compass Pathways | CMPS | New Coverage | Outperform (N/A) |
7.30 (6.58) |
-9.86% | Details | |
| 7/22/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 6/21/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 6/5/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2024 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2024 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2024 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2024 | NewAmsterdam Pharma Co NV | NAMS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2024 | Axsome Therapeutics | AXSM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/16/2024 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Outperform (N/A) |
49.11 (9.92) |
-79.8% | Details | |
| 1/25/2024 | Axsome Therapeutics | AXSM | New Coverage | Outperform (N/A) |
91.78 (162.33) |
76.87% | Details | |
| 11/14/2023 | Design Therapeutics Inc | DSGN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/30/2023 | NewAmsterdam Pharma Co NV | NAMS | New Coverage | Outperform (N/A) |
6.31 (29.86) |
373.22% | Details | |
| 9/5/2023 | Pyxis Oncology Inc. | PYXS | New Coverage | Outperform (N/A) |
2.32 (1.37) |
-40.95% | Details | |
| 8/15/2023 | Design Therapeutics Inc | DSGN | Downgrade | Sector Perform (Outperform) |
7.33 (7.34) |
0.14% | Details | |
| 5/18/2023 | Legend Biotech Corp. | LEGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | Design Therapeutics Inc | DSGN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2023 | Legend Biotech Corp. | LEGN | New Coverage | Outperform (N/A) |
43.82 (18.97) |
-56.71% | Details | |
| 12/8/2022 | Design Therapeutics Inc | DSGN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Design Therapeutics Inc | DSGN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/2/2022 | Design Therapeutics Inc | DSGN | New Coverage | Outperform (N/A) |
11.94 (10.05) |
-15.83% | Details | |
| 4/13/2022 | Edgewise Therapeutics | EWTX | New Coverage | Outperform (N/A) |
8.52 (27.82) |
226.53% | Details |
